Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Prostate Cancer and Prostatic Diseases
|
February 11, 2022
Outcomes in men with metastatic castration-resistant prostate cancer who received sipuleucel-T and no immediate subsequent therapy: experience at Dana Farber and in the PROCEED Registry
Xiao X Wei, Lucia Kwak, Anis Hamid, et al.
The Journal of Endocrinology
|
January 19, 2017
Regulation of aldosterone secretion by mineralocorticoid receptor-mediated signaling
Cherish Chong, Anis Hamid, Tham Yao, et al.
Annals of Hematology
|
February 17, 2016
Hodgkin lymphoma: an Australian experience of ABVD chemotherapy in the modern era
Azim Jalali, Francis J Ha, Geoff Chong, et al.
Cancers
|
May 13, 2023
A Multicenter, Open-Label, Phase I/II Study of FN-1501 in Patients with Advanced Solid Tumors
Gary Edward Richardson, Raed Al-Rajabi, Dipesh Uprety, et al.
JCO Oncology Practice
|
November 3, 2025
Interprovider Variation in Initiation of Bone-Modifying Agents for Patients With Prostate Cancer
Aaron P Mitchell, Andrew Salner, Paul Palyca, et al.
Journal for Immunotherapy of Cancer
|
March 29, 2020
Safety and efficacy of immune checkpoint inhibitors in advanced urological cancers with pre-existing autoimmune disorders: a retrospective international multicenter study
Nieves Martinez Chanza, Wanling Xie, Majd Issa, et al.
Prostate Cancer and Prostatic Diseases
|
January 11, 2022
Definitions of disease burden across the spectrum of metastatic castration-sensitive prostate cancer: comparison by disease outcomes and genomics
Philip Sutera, Kim Van Der Eecken, Amar U Kishan, et al.
The Prostate
|
May 6, 2021
A polymorphism in the promoter of FRAS1 is a candidate SNP associated with metastatic prostate cancer
Victoria Wang, Milan S Geybels, Kristina M Jordahl, et al.
Arxiv
|
April 1, 2025
Causes of evolutionary divergence in prostate cancer
Emre Esentürk, Atef Sahli, Valeriia Haberland, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Prostate Cancer and Prostatic Diseases
|
February 11, 2022
Outcomes in men with metastatic castration-resistant prostate cancer who received sipuleucel-T and no immediate subsequent therapy: experience at Dana Farber and in the PROCEED Registry
Xiao X Wei, Lucia Kwak, Anis Hamid, et al.
The Journal of Endocrinology
|
January 19, 2017
Regulation of aldosterone secretion by mineralocorticoid receptor-mediated signaling
Cherish Chong, Anis Hamid, Tham Yao, et al.
Annals of Hematology
|
February 17, 2016
Hodgkin lymphoma: an Australian experience of ABVD chemotherapy in the modern era
Azim Jalali, Francis J Ha, Geoff Chong, et al.
Cancers
|
May 13, 2023
A Multicenter, Open-Label, Phase I/II Study of FN-1501 in Patients with Advanced Solid Tumors
Gary Edward Richardson, Raed Al-Rajabi, Dipesh Uprety, et al.
JCO Oncology Practice
|
November 3, 2025
Interprovider Variation in Initiation of Bone-Modifying Agents for Patients With Prostate Cancer
Aaron P Mitchell, Andrew Salner, Paul Palyca, et al.
Journal for Immunotherapy of Cancer
|
March 29, 2020
Safety and efficacy of immune checkpoint inhibitors in advanced urological cancers with pre-existing autoimmune disorders: a retrospective international multicenter study
Nieves Martinez Chanza, Wanling Xie, Majd Issa, et al.
Prostate Cancer and Prostatic Diseases
|
January 11, 2022
Definitions of disease burden across the spectrum of metastatic castration-sensitive prostate cancer: comparison by disease outcomes and genomics
Philip Sutera, Kim Van Der Eecken, Amar U Kishan, et al.
The Prostate
|
May 6, 2021
A polymorphism in the promoter of FRAS1 is a candidate SNP associated with metastatic prostate cancer
Victoria Wang, Milan S Geybels, Kristina M Jordahl, et al.
Arxiv
|
April 1, 2025
Causes of evolutionary divergence in prostate cancer
Emre Esentürk, Atef Sahli, Valeriia Haberland, et al.
Page
of 1